OPKO Health, Inc. (LON:0KCS)
1.231
-0.017 (-1.35%)
Feb 12, 2026, 4:57 PM GMT
OPKO Health Revenue
OPKO Health had revenue of $151.67M USD in the quarter ending September 30, 2025, a decrease of -12.65%. This brings the company's revenue in the last twelve months to $642.07M, down -9.75% year-over-year. In the year 2024, OPKO Health had annual revenue of $713.14M, down -17.41%.
Revenue (ttm)
$642.07M
Revenue Growth
-9.75%
P/S Ratio
1.43
Revenue / Employee
$214.24K
Employees
2,997
Market Cap
681.92M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 713.14M | -150.35M | -17.41% |
| Dec 31, 2023 | 863.50M | -140.70M | -14.01% |
| Dec 31, 2022 | 1.00B | -770.52M | -43.42% |
| Dec 31, 2021 | 1.77B | 339.31M | 23.64% |
| Dec 31, 2020 | 1.44B | 533.48M | 59.15% |
| Dec 31, 2019 | 901.94M | -88.33M | -8.92% |
| Dec 31, 2018 | 990.27M | 24.26M | 2.51% |
| Dec 31, 2017 | 966.01M | -151.49M | -13.56% |
| Dec 31, 2016 | 1.12B | 625.76M | 127.25% |
| Dec 31, 2015 | 491.74M | 400.61M | 439.63% |
| Dec 31, 2014 | 91.13M | -5.41M | -5.60% |
| Dec 31, 2013 | 96.53M | 49.49M | 105.19% |
| Dec 31, 2012 | 47.04M | 19.07M | 68.14% |
| Dec 31, 2011 | 27.98M | -515.00K | -1.81% |
| Dec 31, 2010 | 28.49M | 24.08M | 544.95% |
| Dec 31, 2009 | 4.42M | -5.02M | -53.20% |
| Dec 31, 2008 | 9.44M | 8.59M | 1,014.52% |
| Dec 31, 2007 | 847.00K | - | - |
| Dec 31, 2006 | - | - | - |
| Dec 31, 2005 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.67B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Spire Healthcare Group | 1.55B |
| CVS Group | 673.20M |
| Advanced Medical Solutions Group | 220.30M |
| Oxford Nanopore Technologies | 204.69M |
OPKO Health News
- 8 days ago - OPKO Health (OPK) and Entera Bio Expand Collaboration on Oral PTH Treatment - GuruFocus
- 8 days ago - OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism - GlobeNewsWire
- 16 days ago - OPKO Health: Deeply Mispriced Ahead Of Major Catalysts - Seeking Alpha
- 4 weeks ago - OPKO Health, Inc. (OPK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - OPKO Health Inc at JPMorgan Healthcare Conference Transcript - GuruFocus
- 5 weeks ago - OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 5 weeks ago - OPKO Health Bets on RAYALDEE and Pipeline Progress for 2026 Growth - Nasdaq
- 2 months ago - Here's Why You Should Retain OPKO Health Stock in Your Portfolio Now - Nasdaq